---
figid: PMC7565022__cells-09-01973-g004
figtitle: Protein arginine methyl transferase (PRMT)-mediated modulation of glioma-associated
  oncogene (GLI) 1 or GLI2 activity
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Lareunionomyces loeiensis
- Moloney murine leukemia virus
- Paraechinus aethiopicus
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC7565022
filename: cells-09-01973-g004.jpg
figlink: pmc/articles/PMC7565022/figure/cells-09-01973-f004/
number: F4
caption: Protein arginine methyl transferase (PRMT)-mediated modulation of glioma-associated
  oncogene (GLI) 1 or GLI2 activity. PRMT1 methylates an arginine residue at 597 in
  GLI1. This PRMT1-mediated GLI1 methylation assists with the upregulation of GLI1
  activity. Furthermore, methylated GLI1 enhances the expression of some specific
  GLI1 target genes (IGFBP6 and BCL2). Cytoplasmic PRMT5 methylates arginine residues
  at 990 and 1018 in GLI1. This PRMT5-mediated GLI1 methylation inhibits the interactions
  of GLI1 and ITCH–Numb E3 ligase, and stabilizes the GLI1 protein. In contrast, nucleic
  PRMT5 interacts with Menin and represses growth arrest-specific protein (GAS) 1,
  and indirectly downregulates the HH signaling pathway. PRMT7 methylates arginine
  residues at 225 and 227 in GLI2. This PRMT7-mediated GLI2 methylation inhibits the
  binding of Suppressor of Fused (SUFU) to GLI2, resulting in GLI2 activation.
papertitle: 'Fine-Tuning of GLI Activity through Arginine Methylation: Its Mechanisms
  and Function.'
reftext: Yoshinori Abe, et al. Cells. 2020 Sep;9(9):1973.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9489169
figid_alias: PMC7565022__F4
figtype: Figure
redirect_from: /figures/PMC7565022__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7565022__cells-09-01973-g004.html
  '@type': Dataset
  description: Protein arginine methyl transferase (PRMT)-mediated modulation of glioma-associated
    oncogene (GLI) 1 or GLI2 activity. PRMT1 methylates an arginine residue at 597
    in GLI1. This PRMT1-mediated GLI1 methylation assists with the upregulation of
    GLI1 activity. Furthermore, methylated GLI1 enhances the expression of some specific
    GLI1 target genes (IGFBP6 and BCL2). Cytoplasmic PRMT5 methylates arginine residues
    at 990 and 1018 in GLI1. This PRMT5-mediated GLI1 methylation inhibits the interactions
    of GLI1 and ITCH–Numb E3 ligase, and stabilizes the GLI1 protein. In contrast,
    nucleic PRMT5 interacts with Menin and represses growth arrest-specific protein
    (GAS) 1, and indirectly downregulates the HH signaling pathway. PRMT7 methylates
    arginine residues at 225 and 227 in GLI2. This PRMT7-mediated GLI2 methylation
    inhibits the binding of Suppressor of Fused (SUFU) to GLI2, resulting in GLI2
    activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Prmt5
  - Prmt7
  - Itch
  - Gli1
  - Gli2
  - Sufu
  - Numb
  - Men1
  - Gas1
  - Prmt1
  - Wdr77
  - PRMT5
  - PRMT7
  - ITCH
  - GLI1
  - GLI2
  - SUFU
  - NUMB
  - GAS1
  - PRMT1
  - WDR77
  - prmt5
  - prmt7
  - itchb
  - itcha
  - gli1
  - gli2a
  - sufu
  - numb
  - gli
  - prmt1
---
